Details for Patent: 9,486,526
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,486,526 protect, and when does it expire?
Patent 9,486,526 protects TRADJENTA and is included in one NDA.
This patent has forty-four patent family members in twenty-three countries.
Summary for Patent: 9,486,526
| Title: | Treatment for diabetes in patients inappropriate for metformin therapy |
| Abstract: | The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin. |
| Inventor(s): | Dugi; Klaus (Dresden, DE), Graefe-Mody; Eva Ulrike (Ingelheim am Rhein, DE), Harper; Ruth (Reading, GB), Woerle; Hans-Juergen (Munich, DE) |
| Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
| Application Number: | 14/294,630 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,486,526 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,486,526
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | TRADJENTA | linagliptin | TABLET;ORAL | 201280-001 | May 2, 2011 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | METHOD OF TREATING TYPE 2 DIABETES MELLITUS IN PATIENTS WITH SEVERE CHRONIC RENAL IMPAIRMENT AND WHO ARE INELIGIBLE FOR METFORMIN THERAPY BY ADMINISTERING LINAGLIPTIN | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,486,526
International Family Members for US Patent 9,486,526
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 072920 | See Plans and Pricing | |||
| Australia | 2009279085 | See Plans and Pricing | |||
| Brazil | PI0916997 | See Plans and Pricing | |||
| Canada | 2732803 | See Plans and Pricing | |||
| Chile | 2011000259 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
